Kvikk is a B2C Insurtech company disrupting the travel insurance sector through our mobile platform. Designed with millennials, Gen Z and their expectations in mind, our vision is clear: 
Revolutionizing the way we protect ourselves while exploring the world. We are leveraging GEO-fencing technology to distribute, personalize and offer quotes tailored to your location in real-time. No more hassle with paperwork or waiting in line. We are 100% digital and are providing a full insurance experience in the pockets of everyone leaving their homes. In Norway 50% of all young adults don't have travel insurance, and they perceive insurance as complicated, expensive and unavailable. At the same time, the insurance industry lacks digitisation with only 40% of all insurance sales taking place on a digital platform. We have developed travel insurance tailored to the specific needs of each traveller, all within a convenient and user-friendly app. By harnessing the power of GEO-fencing we ensure travellers receive seamless coverage when and where they need it, offering a level of flexibility unseen in the industry. We have built the insurance product, and we are going to build the app. Simen started working on Kvikk while studying Innovation & Management, and has previously been travelling around the world several times and do understand the importance of travel insurance. We honestly believe that insurance companies should do better. In this digital world, insurance should be more available for the customer. There should be possible to buy insurance, get an overview and file claims within minutes, and always available in your own pocket. We also believe in fair and transparent products, where the customer actually gets a personalised products tailored to their own travel pattern. We want to rewrite the rules of insurance by making it available, fair, easy and personalised.

Stack by.me is a social media platform where users can invest together, making investments more engaging and available to non-professionals - especially women. Today, there is a substantial capital gap in Norway and globally. In Norway, the gap is as large as a Norwegian state budget. (which is huge!) - only 20% of the value of Oslo Børs is owned by women today - Women invest 63% less than men, on average - while we only make 11% less - At the same time, 86% of all min. pension receivers are women, so women should be investing more - not less! Why is that? Women tell us - they don´t feel like they have enough knowledge - they don´t know who to ask for help Through the Stack-app, we give them the network to learn from and discuss investments - in an easy and fun way.

We Are Learning is building the next-generation AI-powered course authoring tool — so learning teams can easily create scenario-based, interactive training with 3D Characters and gamified experiences. Born in Norway in 2023 and founded by serial entrepreneurs Rolf Risnes and Lars-Petter W. Kjos (ex-Motimate, acquired by Kahoot! in 2021), we’re a team of learning designers, 3D artists, game devs, and AI engineers bringing our vision to life — fast. If you’re passionate about changing how the world learns, we’d love to hear from you.

BitPet is an AR multiplayer mobile game making physical activity fun and social. Each player has a pet whose health depends on the activity from their step counter, and players can meet each other's pets in multiplayer AR which is fun and social. The idea for the game is based on research by a professor of game technology and co-founder of Kahoot! The game is currently in early beta and will be launched commercially in 2023.

Mobai simplifies everyday life and increases ICT security by using biometrics to: Verify and authenticate people, Detect attacks on facial recognition systems, Detects Face Morph Images in ID photos, and Provide technology to use biometrics in digital signatures. A spin-off from the Norwegian Biometrics Laboratory at the Norwegian University of Science and Technology. We offer: Opportunity to work with products and services that are fundamental to secure everyone a part in a digital world regardless of age, nationality, language, ethnicity, IT literacy, and IT experience.To become a part of a dedicated, talented, and passionate team with international ambitions and international opportunities A job that offers lots of freedom and an equal amount of responsibility and accountability. Professional challenges, significant responsibility, and the opportunity to directly influence products that help shape the future of the biometric industry.Great opportunities for further learning and professional development in one of the fastest-growing areas in the tech industry - academically and professionally. Flexible office arrangements. Physical location, hybrid meeting places, and home office. Modern and central offices in Oslo and GjøvikCompetitive terms and benefits include insurance (health, travel, and pension)

XperiTech is a technology company that offers digital solutions for service providers in the travel industry. Our focus is on seamless customer travel and profiling of local experiences and tourism. Our slogan is "Better technology for better travel experiences". Today, we run the two brands Elveguiden and Campio, and we are an established startup with financial security. Our brands: Elveguiden - Norway's largest provider of salmon fishing. In addition supplier of systems for river management.Campio - Norway's largest portal for camping in Norway, and provider of digital solutions for the industry

We want to make our cities green. Literally. Urban green infrastructure is one of the most important climate adaptation instruments for cities. They help manage water, temperature, air quality and improve life quality. The design process, the sourcing of plants and the maintenance systems for these spaces are however challenging today: they are not fit to properly respond to the ever more demanding regulations and the increased complexity of projects. We are solving this with a platform for all urban green spaces stakeholders. Put simply we want to create the OTOVO of urban green spaces. This means we are orchestrating stakeholders to make sure the right plants are used in the right place to create cities we thrive in.

Happii specializes in executive search, recruitment marketing, and talent management, with a focus on using tailored tools and processes to meet the specific needs of their clients. The company's approach emphasizes building strong relationships to understand and fulfill client goals. Connecting talent to opportunity with precision and a personal touch – that's Happii's magic

Ondego lets you charge your phone on the go through its network of portable batteries so you never have to worry about your battery level again. Users can find our chargers in cafés, restaurants, and other public locations where they can unlock a charger, charge wherever they want and later return to any Ondego station nearby. See this short video (1min) to see how it works:ondego.no

Orgbrain is a next generation portal that is tailor-made for manage digital board meetings and general assembly. The portal gives you everything you need to organize a meeting like meeting planing, video conferencing, shareholder book, digital voting, document storage, distribution of minutes for consultation and signing of minutes with BankID. The system provides proposals for both annual plan, agenda and minutes. Orgbrain also contains a digital board school where users can complete an authorization course in board administration with exams and diplomas. #orgbrain #styreskolen #styret #styrearbeid #styreleder #dagligleder #styreportal #styreplattform #ledelse #digitalisering #maskinlæring "kunstigintelligens #innovasjon

Nutcracker Solutions owns the product StadiaPitch by Bosch Rexroth and have licensed it to Bosch Rexroth until 2038.  The product is sold worldwide by the Bosch Corporation, and Nutcracker is a part of Bosch`s International StadiaPItch sales team. The goal is to reach 4 sales a year. Bosch pays Nutcracker a license fee between €1M - €1.5M per sale. 90% of the fee is due 5 months after Bosch has signed the contract with the stadium. Nutcracker has a flat predictable annual operating cost of €0.4M, regardless of how many StadiaPitch Sales Bosch Rexroth has in that year.  StadiaPitch entered the commercial phase in 2018 and has received an overwhelming market response. StadiaPitch is today included in the architectural drawings on three stadium projects, and Bosch has solid interest from several of the largest clubs in the world. StadiaPitch has received interest from architects, stadiums, and other stakeholders from 25 countries in the last 12 months.  Nutcracker is a dividend stock and the company is priced at 40 MNOK – pre-money. Nutcracker runs a Private Placement of 1OMNOK through a share issue that will equal to 20% of the new total number of shares. This funding will be spent on IPR, activities that enhance Bosch`s global sales work, and operating costs until we get income from the first Bosch contract. We pay a preference dividend equivalent to 50% of the investment for new investors. We have a commitment of 9 MNOK and we close the placement when we reach after the NXT 2019 events.

Sensar Marine is set out to revolutionize the boating industry. Using the latest sensor and wireless technology we will improve safety at sea, protect the boat when not in use and give boat owners and their families peace of mind wherever they are. Sensar Marine makes products designed to improve the relationship between a boat and its owner. Our flagship product is a boat monitoring system designed specifically for use in boats, which could run 24/7, 365 days a year without draining boat batteries. Our service has introduced a way for boaters to monitor their boats from their mobile phones, and be notified when their boat needs attention. To date, SmartBoat One has been installed in thousands of boats of all types, in harbors around the world.

EpiGuard AS is an innovative Norwegian Medical Technology Company established in 2015 by a group of doctors at the Oslo University Hospital (OUS) together with co-founders Inven2, Eker Group AS, and Hansen Protection AS. EpiGuard has evolved into a highly skilled knowledge-based company. The business model is to develop and manufacture high-end medical equipment for the safe transport of contagious patients. The products will be distributed globally through strategic partners. Currently, the main product is the medical isolation and transportation system, EpiShuttle. The system is developed by clinical experts at OUS, with first-hand experience in providing advanced treatment and transportation of patients with highly infectious diseases, such as Ebola.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Innovation Dock is a living, energetic innovation hub for entrepreneurs, innovators, and growth companies in Stavanger, Norway. Four buildings of prime office space, co-working, and conference facilities with a front-row view of the fjords and mountains, located in the most energetic part of Stavanger city center; the growing Stavanger east.